The impact of treatment facility type on the survival of brain metastases patients regardless of the primary cancer type.

Saber AminMichael BaineJane MezaChi Lin

Published in: BMC cancer (2021)

In this extensive analysis of the NCDB, receiving treatment at academic centers was associated with significantly improved OS compared to treatment at non-academic centers.

Keyphrases

small cell lung cancer
end stage renal disease
brain metastases
chronic kidney disease
ejection fraction
combination therapy
young adults
patient reported outcomes
lymph node metastasis
patient reported